Mergers & Acquisitions - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

1 to 25 of 659 results

Allergan moves to block Valeant and Pershing Square from voting shares acquired in violation of insider trading laws

27-08-2014

Hostile takeover target Allergan has asked the US District Court for the Central District of California…

AllerganLegalMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals International

China Biologic to up equity stake in Guizhou Taibang

China Biologic to up equity stake in Guizhou Taibang

26-08-2014

Plasma-based biopharma firm China Biologic Products says that its wholly-owned subsidiary Guiyang Dalin…

ChinaChina Biologic ProductsGuizhou Eakan PharmaceuticalGuizhou Taibang BiologicalMergers & AcquisitionsPharmaceutical

Roche makes another acquisition, paying $8.3 billion for InterMune

Roche makes another acquisition, paying $8.3 billion for InterMune

25-08-2014

Announcing its fourth acquisition this year, Swiss pharma major Roche said on Sunday that it has entered…

EsbrietInterMuneMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryRoche

Pershing Square and other shareholders call for special meeting regarding Allergan hostile bid

Pershing Square and other shareholders call for special meeting regarding Allergan hostile bid

23-08-2014

Pershing Square Capital Management, the largest shareholder of Allergan, which is the subject of a $53…

AllerganManagementMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals International

Pfizer could try to acquire Actavis as back-up to a further bid for AstraZeneca

Pfizer could try to acquire Actavis as back-up to a further bid for AstraZeneca

22-08-2014

While speculation continues as to whether Pfizer will resume its attempts to buy AstraZeneca, Pfizer…

ActavisAstraZenecaBusiness FinanceIrelandMergers & AcquisitionsPfizerPharmaceuticalSwedenUKUnited StatesUSA

Mood lifts for Medtech in first half of 2014, while Pharma sector faces new struggles

Mood lifts for Medtech in first half of 2014, while Pharma sector faces new struggles

20-08-2014

An M&A frenzy that accounted for nearly $90 billion of equity set the pace for the first half of 2014…

FinancialGlobalJonathan GardnerMergers & AcquisitionsPharmaceutical

EXPERT VIEW: Pfizer and AstraZeneca, a marriage not to be – yet?

EXPERT VIEW: Pfizer and AstraZeneca, a marriage not to be – yet?

19-08-2014

Mergers and acquisitions may excite the markets and shareholders on both sides but their record of success…

GlobalInterviewsMergers & AcquisitionsPharmaceutical

Roche said to be eyeing full control of Chugai

Roche said to be eyeing full control of Chugai

18-08-2014

Although the Swiss drug major has not issued a confirmation, media reports say Roche is close to acquiring…

Business FinanceChugai PharmaceuticalChugai Pharmaceutical Co.Chugai PharmaceuticalsHoffmann-La RocheInvestmentMergers & AcquisitionsPharmaceuticalRoche

$260.2 billion-worth of deals in the global PMB industry in first-half 2014

$260.2 billion-worth of deals in the global PMB industry in first-half 2014

12-08-2014

Global pharma, medical and biotechnology (PMB) M&A activity during the first half of 2014 hit the highest…

Business FinanceGlobalMergers & AcquisitionsPharmaceutical

Allergan and Valeant receive second request for information from US Federal Trade Commission

Allergan and Valeant receive second request for information from US Federal Trade Commission

12-08-2014

US Botox maker Allergan has received a request for additional information from the US Federal Trade Commission…

AllerganBusiness FinanceMergers & AcquisitionsPharmaceuticalUSAValeant PharmaceuticalsValeant Pharmaceuticals International

Sun Pharma’s takeover of Ranbaxy comes to attention of Competition Commission

Sun Pharma’s takeover of Ranbaxy comes to attention of Competition Commission

11-08-2014

The deal between Indian generics company Sun Pharmaceutical Industries which acquired fellow Indian drug…

CCIGenericsIndiaMergers & AcquisitionsPharmaceuticalRanbaxy LaboratoriesSun Pharmaceutical Industries

Walgreens to buy remainder of Boots Alliance, but shuns inversion

06-08-2014

US pharmacy giant Walgreen has exercised its option to buy the remaining 55% of European pharmacy retailer…

Alliance BootsEuropeMarkets & MarketingMergers & AcquisitionsPharmaceuticalWalgreens

Kyowa Hakko Kirin subsidiary ProStrakan acquires Archimedes

Kyowa Hakko Kirin subsidiary ProStrakan acquires Archimedes

06-08-2014

Japanese drugmaker Kyowa Hakko Kirin subsidiary, the Scotland-based ProStrakan, has acquired Archimedes…

ArchimedesArchimedes PharmaFentanylJapanKyowa Hakko KirinMergers & AcquisitionsNovo A/SNovo NordiskPharmaceuticalProStrakan

Allergan attacks Valeant’s financial results

Allergan attacks Valeant’s financial results

06-08-2014

US Botox maker Allergan, the subject of a hostile $53 billion takeover attempt by Canada’s Valeant…

AllerganBusiness FinanceCanadaFinancialMergers & AcquisitionsPharmaceuticalUSAValeant PharmaceuticalsValeant Pharmaceuticals International

Allergan sues Valeant and Pershing Square, alleging insider trading

Allergan sues Valeant and Pershing Square, alleging insider trading

02-08-2014

US Botox maker Allergan, the subject of a hostile $53 billion takeover attempt by Canada’s Valeant…

AllerganBusiness FinanceLegalMergers & AcquisitionsPharmaceuticalUSAValeant Pharmaceuticals International

Altacor growth to accelerate after acquisition by Esperante

Altacor growth to accelerate after acquisition by Esperante

01-08-2014

The private, Netherlands-based life science investment company Esperante says it has completed the acquisition…

AltacorDean SlagelEsperanteIn vitro diagnosticsMergers & AcquisitionsNetherlandsNicOxNYSE EuronextOphthalmicsPharmaceuticalProducerUK

Meda in $3.1 billion deal to acquire Italy’s Rottapharm

Meda in $3.1 billion deal to acquire Italy’s Rottapharm

31-07-2014

Sweden’s Meda says it has entered into a definitive agreement to acquire Rottapharm Madaus, an Italian…

Business FinanceItalyMedaMergers & AcquisitionsMergers and acquisitionsPharmaceuticalRottapharm MadausSwedenSweden

Pfizer spends $635 million on acquiring two Baxter vaccines

Pfizer spends $635 million on acquiring two Baxter vaccines

30-07-2014

US pharma giant Pfizer has entered into a definitive agreement to acquire Baxter International portfolio…

Baxter InternationalMergers & AcquisitionsPfizerPharmaceuticalProductionUSAVaccines

AstraZeneca to acquire Almirall’s respiratory franchise, for up to $2.1 billion

AstraZeneca to acquire Almirall’s respiratory franchise, for up to $2.1 billion

30-07-2014

Anglo-Swedish pharma major AstraZeneca has entered an agreement to gain rights to the respiratory franchise…

AlmirallAstraZenecaEkliraMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

PaxVax acquires the FDA-approved typhoid vaccine Vivotif

PaxVax acquires the FDA-approved typhoid vaccine Vivotif

29-07-2014

Privately-held California, USA-based specialty vaccine firm PaxVax says it has acquired the oral typhoid…

LicensingMergers & AcquisitionsPaxVaxPharmaceuticalProductionSwitzerlandVaccinesVivotif

Reckitt Benckiser to spin out pharma; GSK views Consumer options

Reckitt Benckiser to spin out pharma; GSK views Consumer options

28-07-2014

UK-based consumer goods giant Reckitt Benckiser plans to spin off its USA-based pharmaceutical business,…

FinancialGlaxoSmithKlineMergers & AcquisitionsNeurologicalPharmaceuticalReckitt BenckiserSuboxoneUK

Retrophin proposes acquisition of Clinuvel Pharma for $95 million

Retrophin proposes acquisition of Clinuvel Pharma for $95 million

28-07-2014

The USA’s Retrophin has submitted an unsolicited $95 million takeover proposal to the board of directors…

AfamelanotideAustraliaClinuvel PharmaceuticalsDermatologicalsMergers & AcquisitionsPharmaceuticalRare diseasesRetrophinScenesse

Stallergenes expands in Latin American with acquisition of Alergo Pharma

Stallergenes expands in Latin American with acquisition of Alergo Pharma

22-07-2014

French allergen specialist Stallergenes said this morning that it has acquired full ownership of Alergo…

Alergo PharmaAllergologyArgentinaImmunologyMedicineMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryStallergenes

Shire finally accepts AbbVie’s takeover offer

Shire finally accepts AbbVie’s takeover offer

18-07-2014

After a protracted and at times hostile courtship, Ireland-headquartered drugmaker Shire has finally…

AbbVieHumiraMergers & AcquisitionsNeurologicalPharmaceuticalRare diseasesShireUSA

1 to 25 of 659 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top